Homocysteine and Coronary Heart Disease: Meta-analysis of MTHFR Case-Control Studies, Avoiding Publication Bias
Open accessThe DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Moderately elevated blood levels of homocysteine are weakly correlated with coronary heart disease (CHD) risk, but causality remains uncertain. When folate levels are low, the TT genotype of the common C677T polymorphism (rs1801133) of the methylene tetrahydrofolate reductase gene (MTHFR) appreciably increases homocysteine levels, so "Mendelian randomization" studies using this variant as an instrumental variable could help test causality. METHODS AND FINDINGS: Nineteen unpublished datasets were obtained (total 48,175 CHD cases and 67,961 controls) in which multiple genetic variants had been measured, including MTHFR C677T. These datasets did not include measurements of blood homocysteine, but homocysteine levels would be expected to be about 20% higher with TT than with CC genotype in the populations studied. In meta-analyses of these unpublished datasets, the case-control CHD odds ratio (OR) and 95% CI comparing TT versus CC homozygotes was 1.02 (0.98-1.07; p = 0.28) overall, and 1.01 (0.95-1.07) in unsupplemented low-folate populations. By contrast, in a slightly updated meta-analysis of the 86 published studies (28,617 CHD cases and 41,857 controls), the OR was 1.15 (1.09-1.21), significantly discrepant (p = 0.001) with the OR in the unpublished datasets. Within the meta-analysis of published studies, the OR was 1.12 (1.04-1.21) in the 14 larger studies (those with variance of log OR<0.05; total 13,119 cases) and 1.18 (1.09-1.28) in the 72 smaller ones (total 15,498 cases). CONCLUSIONS: The CI for the overall result from large unpublished datasets shows lifelong moderate homocysteine elevation has little or no effect on CHD. The discrepant overall result from previously published studies reflects publication bias or methodological problems.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139 · cited 1×
“Heterogeneity was assessed using chi-squared tests [28], also citing I 2 = 100%(1 2 [degrees of freedom]/[chi-squared test statistic]) [29].”
MethodDavey Smith, G., & Ebrahim, S. (2003) · International Journal of Epidemiology · doi:10.1093/ije/dyg070 · Cited by 5,882 · cited 4×
“Previous meta-analyses of published studies [6,9,10– 12, 14, 20 ] were updated”
BackgroundMethodInfluentialFrosst, P., Blom, H. J., Milos, R., Goyette, P., Sheppard, C. A., Matthews, R. G., Boers, G. J. H., den Heijer, M., Kluijtmans, L. A. J., van den Heuve, L. P., et al. (1995) · Nature Genetics · doi:10.1038/ng0595-111 · Cited by 5,653
The combination of estimates from different experiments
Cochran, W. G. (1954) · Biometrics · doi:10.2307/3001666 · Cited by 5,380 · cited 1×
“Heterogeneity was assessed using chi-squared tests [28], also citing I 2 = 100%(1 2 [degrees of freedom]/[chi-squared test statistic]) [29].”
MethodPublication bias in clinical research
Easterbrook, P. J., Gopalan, R., Berlin, J. A., & Matthews, D. R. (1991) · The Lancet · doi:10.1016/0140-6736(91)90201-y · Cited by 3,109
Tunstall-Pedoe, H., Kuulasmaa, K., Amouyel, P., Arveiler, D., Rajakangas, A. M., & Pajak, A. (1994) · Circulation · doi:10.1161/01.cir.90.1.583 · Cited by 2,263 · cited 1×
“CHD was defined as death from CHD, myocardial infarction (by WHO MONICA criteria [19]), or angiographic stenosis (involving at least 50% of a major coronary artery).”
MethodHyperhomocysteinemia: An Independent Risk Factor for Vascular Disease
Clarke, R., Daly, L., Robinson, K., Naughten, E., Cahalane, S., Fowler, B., & Graham, I. (1991) · New England Journal of Medicine · doi:10.1056/nejm199104253241701 · Cited by 2,161 · cited 3×
“It was therefore hypothesised that, even within the normal range of plasma homocysteine concentrations, higher levels might appreciably increase CHD risk [3].”
BackgroundResultSelf-citationHomocysteine and Risk of Ischemic Heart Disease and Stroke: A Meta-analysis
Homocysteine Studies Collaboration (2002) · JAMA · doi:10.1001/jama.288.16.2015 · Cited by 2,059
Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis
Wald, D. S., Law, M., & Morris, J. K. (2002) · BMJ · doi:10.1136/bmj.325.7374.1202 · Cited by 1,946
Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease
Cardiogenics, Schunkert, H., the CARDIoGRAM Consortium, König, I. R., Kathiresan, S., Reilly, M. P., Assimes, T. L., Holm, H., Preuss, M., Stewart, A. F. R., et al. (2011) · Nature Genetics · doi:10.1038/ng.784 · Cited by 1,866 · cited 2×
“Genetic epidemiology of the effects of common polymorphisms on common diseases is increasingly dominated by consortia of GWA studies with tens of thousands of cases and large panels of tens or hundreds of thousands of polymorphisms [15,16].”
BackgroundMethodSelf-citation
Cited by
Biomarkers of Nutrition for Development—Folate Review
Bailey, L. B., Stover, P. J., McNulty, H., Fenech, M. F., Gregory, J. F., Mills, J. L., Pfeiffer, C. M., Fazili, Z., Zhang, M., Ueland, P. M., et al. (2015) · The Journal of Nutrition · doi:10.3945/jn.114.206599 · Cited by 1,136
Mendelian randomization studies: a review of the approaches used and the quality of reporting
Boef, A. G. C., Dekkers, O. M., & le Cessie, S. (2015) · International Journal of Epidemiology · doi:10.1093/ije/dyv071 · Cited by 610
Liew, S.-C., & Gupta, E. D. (2015) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2014.10.004 · Cited by 466
Bioactive phytochemicals in barley
Idehen, E., Tang, Y., & Sang, S. (2017) · Journal of Food and Drug Analysis · doi:10.1016/j.jfda.2016.08.002 · Cited by 358
Mendelian randomization: where are we now and where are we going?
Burgess, S., Timpson, N. J., Ebrahim, S., & Davey Smith, G. (2015) · International Journal of Epidemiology · doi:10.1093/ije/dyv108 · Cited by 304
Davey Smith, G., Holmes, M. V., Davies, N. M., & Ebrahim, S. (2020) · European Journal of Epidemiology · doi:10.1007/s10654-020-00622-7 · Cited by 287
Homocysteine – from disease biomarker to disease prevention
Smith, A. D., & Refsum, H. (2021) · Journal of Internal Medicine · doi:10.1111/joim.13279 · Cited by 261
Ried, K., & Fakler, P. (2014) · Integrated Blood Pressure Control · doi:10.2147/ibpc.s51434 · Cited by 198
“However, whether elevated levels of HCy are primary or secondary risk factors for cardiovascular disease is less clear.(115,116) There is a clear negative correlation between elevated HCy levels and brain and cognitive function.”
van Meurs, J. B., Pare, G., Schwartz, S. M., Hazra, A., Tanaka, T., Vermeulen, S. H., Cotlarciuc, I., Yuan, X., Mälarstig, A., Bandinelli, S., et al. (2013) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.112.044545 · Cited by 198
Self-citationACMG Practice Guideline: lack of evidence for MTHFR polymorphism testing
Hickey, S. E., Curry, C. J., & Toriello, H. V. (2013) · Genetics in Medicine · doi:10.1038/gim.2012.165 · Cited by 175
Hyperhomocysteinaemia and vascular injury: advances in mechanisms and drug targets
Fu, Y., Wang, X., & Kong, W. (2018) · British Journal of Pharmacology · doi:10.1111/bph.13988 · Cited by 170
“as HHcy has also been identified as a risk factor for these diseases (Fallon and BenShlomo, 2003; Ravaglia et al., 2005; Takagi and Umemoto, 2005; Holmes et al., 2011; Clarke et al., 2012; Liu et al., 2012, 2016; Luo et al., 2014; Kim et al., 2015; Wang et al., 2015b).”
BackgroundResultInfluentialTriangulating Evidence through the Inclusion of Genetically Informed Designs
Munafò, M. R., Higgins, J. P. T., & Smith, G. D. (2021) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a040659 · Cited by 125
SARZYNSKI, M. A., RICE, T. K., DESPRÉS, J.-P., PÉRUSSE, L., TREMBLAY, A., STANFORTH, P. R., TCHERNOF, A., BARBER, J. L., FALCIANI, F., CLISH, C., et al. (2022) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000002859 · Cited by 62
Nitrous oxide: are we still in equipoise? A qualitative review of current controversies
de Vasconcellos, K., & Sneyd, J. R. (2013) · British Journal of Anaesthesia · doi:10.1093/bja/aet215 · Cited by 52
Bjørndal, B., Ramsvik, M., Lindquist, C., Nordrehaug, J., Bruheim, I., Svardal, A., Nygård, O., & Berge, R. (2015) · Marine Drugs · doi:10.3390/md13095706 · Cited by 20
“Elevated plasma total homocysteine (tHcy) increases the likelihood of endothelial cell injury and has been implicated as an independent risk factor for atherosclerotic and cardiovascular disease [7], although its direct association to ischemic stroke has been disputed in recent meta-analyses [8,9].”
Background
Metadata
- Authors
- Clarke, R., Bennett, D. A., Parish, S., Verhoef, P., Dötsch-Klerk, M., Lathrop, M., Xu, P., Nordestgaard, B. G., Holm, H., Hopewell, J. C., Saleheen, D., Tanaka, T., Anand, S. S., Chambers, J. C., Kleber, M. E., Ouwehand, W. H., Yamada, Y., Elbers, C., Peters, B., Stewart, A. F. R., Reilly, M. M., Thorand, B., Yusuf, S., Engert, J. C., Assimes, T. L., Kooner, J., Danesh, J., Watkins, H., Samani, N. J., Collins, R., Peto, R., & for the MTHFR Studies Collaborative Group
- Venue
- PLoS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-02-21
- Volume
- 9
- Issue
- 2
- Pages
- e1001177
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- OpenAlex
- W2038932414
- Cited by
- 206
- References
- 34
- FWCI
- 4.53
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.